This inventor holds 1 USPTO granted patent. Top assignee: Smithkline Beecham Seiyaku K.k.. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001
Title: Kenichi Kobayashi: Innovator in Cancer Treatment
Introduction
Kenichi Kobayashi is a notable inventor based in Urawa, Japan. He has made significant contributions to the field of cancer treatment through his innovative research and patent.
Latest Patents
Kobayashi holds a patent for a method of treating cancer in patients using cimetidine. This invention demonstrates that cimetidine can inhibit the expression of E-selectin, which is crucial for the attachment of cancer cells to the vascular wall. His research indicates that cimetidine can effectively inhibit metastasis in patients whose specimens show strong staining for sialyl Lewis X and sialyl Lewis A antigens. This groundbreaking work has the potential to improve treatment outcomes for cancer patients.
Career Highlights
Kenichi Kobayashi is associated with SmithKline Beecham Seiyaku K.K., where he has been able to apply his research in a practical setting. His work has garnered attention for its innovative approach to cancer treatment.
Collaborations
Kobayashi has collaborated with notable colleagues such as Sumio Matsumoto and Takashi Okamoto. Their combined expertise has contributed to the advancement of cancer treatment methodologies.
Conclusion
Kenichi Kobayashi's contributions to cancer treatment through his patent on cimetidine highlight his role as an innovator in the medical field. His work continues to inspire advancements in cancer therapies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile